A Neuroscientist by training, Tom has worked in most therapeutic areas during time at Ipsen, Parexel and as a freelance consultant. Now at Accenture, he continues to represent clients to EMA and to facilitate drug development strategies; but also works with emergent technologies/concepts such as machine learning and precision medicine; some of which will hopefully address the challenges we face from regulatory pressure, squeezed resources, and a rapidly coalescing healthcare system.